George Bickerstaff Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for George Bickerstaff.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of George Bickerstaff. George Bickerstaff is Director in ARIAD PHARMACEUTICALS INC ($ARIA) and Director in VION PHARMACEUTICALS INC ($VION) and Director in INOVIO PHARMACEUTICALS, INC. ($GEB) and Director in Innoviva, Inc. ($THRX) and Director in CareDx, Inc. ($CDNA) and Director in Axovant Sciences Ltd. ($AXON).
Latest Insider Trading Transactions of George Bickerstaff
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ARIA, CDNA, THRX, GEB, AXON, VION
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 20 2021 | THRX | Innoviva, Inc. | Bickerstaff George | Director | Grant | A | 0.00 | 17,482 | 0 | 104,560 | 87.1 K to 104.6 K (+20.08 %) |
May 13 2021 | CDNA | CareDx, Inc. | Bickerstaff George | Director | Sell | S | 63.75 | 600 | 38,248 | 70,938 | 71.5 K to 70.9 K (-0.84 %) |
May 13 2021 | CDNA | CareDx, Inc. | Bickerstaff George | Director | Sell | S | 63.03 | 9,400 | 592,499 | 71,538 | 80.9 K to 71.5 K (-11.61 %) |
Apr 05 2021 | CDNA | CareDx, Inc. | Bickerstaff George | Director | Grant | A | 0.00 | 193 | 0 | 80,938 | 80.7 K to 80.9 K (+0.24 %) |
Dec 14 2020 | CDNA | CareDx, Inc. | Bickerstaff George | Director | Sell | S | 72.84 | 2,076 | 151,219 | 80,487 | 82.6 K to 80.5 K (-2.51 %) |
Dec 14 2020 | CDNA | CareDx, Inc. | Bickerstaff George | Director | Sell | S | 72.04 | 3,224 | 232,248 | 82,563 | 85.8 K to 82.6 K (-3.76 %) |
Dec 14 2020 | CDNA | CareDx, Inc. | Bickerstaff George | Director | Sell | S | 71.10 | 4,700 | 334,177 | 85,787 | 90.5 K to 85.8 K (-5.19 %) |
Oct 02 2020 | CDNA | CareDx, Inc. | Bickerstaff George | Director | Grant | A | 0.00 | 444 | 0 | 90,487 | 90 K to 90.5 K (+0.49 %) |
Jul 06 2020 | CDNA | CareDx, Inc. | Bickerstaff George | Director | Grant | A | 0.00 | 527 | 0 | 90,043 | 89.5 K to 90 K (+0.59 %) |
Jul 06 2020 | CDNA | CareDx, Inc. | Bickerstaff George | Director | Grant | A | 0.00 | 669 | 0 | 96,326 | 95.7 K to 96.3 K (+0.70 %) |
Jun 19 2020 | CDNA | CareDx, Inc. | Bickerstaff George | Director | Option Exercise | A | 31.35 | 4,978 | 156,060 | 4,978 | |
Jun 19 2020 | CDNA | CareDx, Inc. | Bickerstaff George | Director | Option Exercise | A | 31.35 | 4,978 | 156,060 | 4,978 | |
Jun 19 2020 | CDNA | CareDx, Inc. | Bickerstaff George | Director | Grant | A | 0.00 | 3,190 | 0 | 88,847 | 85.7 K to 88.8 K (+3.72 %) |
Jun 19 2020 | CDNA | CareDx, Inc. | Bickerstaff George | Director | Grant | A | 0.00 | 3,190 | 0 | 88,847 | 85.7 K to 88.8 K (+3.72 %) |
May 13 2020 | CDNA | CareDx, Inc. | Bickerstaff George | Director | Sell | S | 27.65 | 10,000 | 276,458 | 85,657 | 95.7 K to 85.7 K (-10.45 %) |
Jan 03 2020 | CDNA | CareDx, Inc. | Bickerstaff George | Director | Grant | A | 0.00 | 653 | 0 | 95,657 | 95 K to 95.7 K (+0.69 %) |
Jan 03 2020 | CDNA | CareDx, Inc. | Bickerstaff George | Director | Grant | A | 0.00 | 653 | 0 | 95,657 | 95 K to 95.7 K (+0.69 %) |
Oct 02 2019 | CDNA | CareDx, Inc. | Bickerstaff George | Director | Grant | A | 0.00 | 541 | 0 | 95,004 | 94.5 K to 95 K (+0.57 %) |
Jul 02 2019 | CDNA | CareDx, Inc. | Bickerstaff George | Director | Grant | A | 0.00 | 468 | 0 | 94,463 | 94 K to 94.5 K (+0.50 %) |
Jun 19 2019 | CDNA | CareDx, Inc. | Bickerstaff George | Director | Option Exercise | A | 38.26 | 4,152 | 158,856 | 4,152 | |
Jun 19 2019 | CDNA | CareDx, Inc. | Bickerstaff George | Director | Grant | A | 0.00 | 2,613 | 0 | 93,995 | 91.4 K to 94 K (+2.86 %) |
May 24 2019 | THRX | Innoviva, Inc. | Bickerstaff George | Director | Grant | A | 0.00 | 16,399 | 0 | 70,161 | 53.8 K to 70.2 K (+30.50 %) |
Apr 17 2019 | CDNA | CareDx, Inc. | Bickerstaff George | Director | Option Exercise | X | 1.12 | 4,415 | 4,945 | 0 | |
Apr 17 2019 | CDNA | CareDx, Inc. | Bickerstaff George | Director | Option Exercise | P | 1.12 | 4,415 | 4,945 | 4,415 | |
Apr 17 2019 | CDNA | CareDx, Inc. | Bickerstaff George | Director | Buy | X | 1.12 | 4,415 | 4,945 | 91,382 | 87 K to 91.4 K (+5.08 %) |
Apr 17 2019 | AXON | Axovant Sciences L ... | Bickerstaff George | Director | Option Exercise | A | 1.06 | 255,000 | 270,300 | 255,000 | |
Apr 03 2019 | CDNA | CareDx, Inc. | Bickerstaff George | Director | Grant | A | 0.00 | 514 | 0 | 86,967 | 86.5 K to 87 K (+0.59 %) |
Mar 21 2019 | CDNA | CareDx, Inc. | Bickerstaff George | Director | Option Exercise | X | 1.12 | 25,000 | 28,000 | 0 | |
Mar 21 2019 | CDNA | CareDx, Inc. | Bickerstaff George | Director | Option Exercise | X | 1.12 | 7,980 | 8,938 | 0 | |
Mar 21 2019 | CDNA | CareDx, Inc. | Bickerstaff George | Director | Option Exercise | P | 1.12 | 25,000 | 28,000 | 25,000 | |
Mar 21 2019 | CDNA | CareDx, Inc. | Bickerstaff George | Director | Option Exercise | P | 1.12 | 7,980 | 8,938 | 7,980 | |
Mar 21 2019 | CDNA | CareDx, Inc. | Bickerstaff George | Director | Buy | X | 1.12 | 25,000 | 28,000 | 86,453 | 61.5 K to 86.5 K (+40.68 %) |
Mar 21 2019 | CDNA | CareDx, Inc. | Bickerstaff George | Director | Buy | X | 1.12 | 7,980 | 8,938 | 61,453 | 53.5 K to 61.5 K (+14.92 %) |
Feb 22 2019 | THRX | Innoviva, Inc. | Bickerstaff George | Director | Buy | P | 14.90 | 10,000 | 148,958 | 38,762 | 28.8 K to 38.8 K (+34.77 %) |
Jan 03 2019 | CDNA | CareDx, Inc. | Bickerstaff George | Director | Grant | A | 0.00 | 535 | 0 | 53,473 | 52.9 K to 53.5 K (+1.01 %) |
Oct 02 2018 | CDNA | CareDx, Inc. | Bickerstaff George | Director | Grant | A | 0.00 | 734 | 0 | 52,938 | 52.2 K to 52.9 K (+1.41 %) |
Aug 13 2018 | AXON | Axovant Sciences L ... | Bickerstaff George | Director | Buy | P | 2.07 | 25,000 | 51,750 | 50,000 | 25 K to 50 K (+100.00 %) |
Jul 03 2018 | CDNA | CareDx, Inc. | Bickerstaff George | Director | Grant | A | 0.00 | 1,197 | 0 | 52,204 | 51 K to 52.2 K (+2.35 %) |
Jul 03 2018 | CDNA | CareDx, Inc. | Bickerstaff George | Director | Option Exercise | A | 14.74 | 15,000 | 221,100 | 15,000 | |
Jul 03 2018 | CDNA | CareDx, Inc. | Bickerstaff George | Director | Grant | A | 0.00 | 5,000 | 0 | 51,007 | 46 K to 51 K (+10.87 %) |
Apr 26 2018 | THRX | Innoviva, Inc. | Bickerstaff George | Director | Grant | A | 0.00 | 14,249 | 0 | 28,762 | 14.5 K to 28.8 K (+98.18 %) |
Apr 04 2018 | CDNA | CareDx, Inc. | Bickerstaff George | Director | Grant | A | 0.00 | 2,221 | 0 | 46,007 | 43.8 K to 46 K (+5.07 %) |
Mar 22 2018 | GEB | INOVIO PHARMACEUTI ... | Bickerstaff George | Director | Option Exercise | M | 0.00 | 4,090 | 0 | 8,180 | |
Mar 22 2018 | GEB | INOVIO PHARMACEUTI ... | Bickerstaff George | Director | Buy | M | 0.00 | 4,090 | 0 | 4,090 | 0 to 4.1 K |
Feb 15 2018 | AXON | Axovant Sciences L ... | Bickerstaff George | Director | Option Exercise | A | 1.81 | 150,000 | 271,500 | 150,000 | |
Jan 02 2018 | CDNA | CareDx, Inc. | Bickerstaff George | Director | Grant | A | 0.00 | 2,004 | 0 | 43,786 | 41.8 K to 43.8 K (+4.80 %) |
Dec 21 2017 | THRX | Innoviva, Inc. | Bickerstaff George | Director | Grant | A | 0.00 | 14,513 | 0 | 14,513 | 0 to 14.5 K |
Nov 13 2017 | CDNA | CareDx, Inc. | Bickerstaff George | Director | Option Exercise | A | 5.49 | 6,679 | 36,668 | 6,679 | |
Nov 13 2017 | CDNA | CareDx, Inc. | Bickerstaff George | Director | Option Exercise | D | 12.40 | 10,948 | 135,755 | 0 | |
Oct 04 2017 | CDNA | CareDx, Inc. | Bickerstaff George | Director | Grant | A | 0.00 | 5,951 | 0 | 41,782 | 35.8 K to 41.8 K (+16.61 %) |
Jul 14 2017 | CDNA | CareDx, Inc. | Bickerstaff George | Director | Option Exercise | A | 1.22 | 15,000 | 18,300 | 15,000 | |
Jul 14 2017 | CDNA | CareDx, Inc. | Bickerstaff George | Director | Grant | A | 0.00 | 5,000 | 0 | 35,831 | 30.8 K to 35.8 K (+16.22 %) |
May 15 2017 | GEB | INOVIO PHARMACEUTI ... | Bickerstaff George | Director | Option Exercise | A | 7.14 | 12,500 | 89,250 | 12,500 | |
May 15 2017 | GEB | INOVIO PHARMACEUTI ... | Bickerstaff George | Director | Option Exercise | A | 0.00 | 7,669 | 0 | 7,669 | |
Mar 23 2017 | GEB | INOVIO PHARMACEUTI ... | Bickerstaff George | Director | Option Exercise | A | 0.00 | 12,270 | 0 | 12,270 | |
Mar 23 2017 | GEB | INOVIO PHARMACEUTI ... | Bickerstaff George | Director | Option Exercise | A | 5.86 | 20,000 | 117,200 | 20,000 | |
Feb 16 2017 | ARIA | ARIAD PHARMACEUTIC ... | Bickerstaff George | Director | Option Exercise | D | 23.82 | 25,000 | 595,500 | 0 | |
Feb 16 2017 | ARIA | ARIAD PHARMACEUTIC ... | Bickerstaff George | Director | Option Exercise | D | 6.65 | 75,000 | 498,750 | 0 | |
Feb 16 2017 | ARIA | ARIAD PHARMACEUTIC ... | Bickerstaff George | Director | Sell | D | 0.00 | 18,008 | 0 | 0 | 18 K to 0 (-100.00 %) |
Feb 01 2017 | ARIA | ARIAD PHARMACEUTIC ... | Bickerstaff George | Director | Option Exercise | A | 23.82 | 25,000 | 595,500 | 25,000 | |
Feb 01 2017 | ARIA | ARIAD PHARMACEUTIC ... | Bickerstaff George | Director | Grant | A | 0.00 | 12,500 | 0 | 18,008 | 5.5 K to 18 K (+226.94 %) |
Feb 01 2017 | ARIA | ARIAD PHARMACEUTIC ... | Bickerstaff George | Director | Grant | A | 0.00 | 5,508 | 0 | 5,508 | 0 to 5.5 K |
Jan 04 2017 | CDNA | CareDx, Inc. | Bickerstaff George | Director | Grant | A | 0.00 | 1,443 | 0 | 18,678 | 17.2 K to 18.7 K (+8.37 %) |
Oct 04 2016 | CDNA | CareDx, Inc. | Bickerstaff George | Director | Grant | A | 0.00 | 1,089 | 0 | 17,235 | 16.1 K to 17.2 K (+6.74 %) |
Jul 19 2016 | CDNA | CareDx, Inc. | Bickerstaff George | Director | Option Exercise | A | 4.95 | 9,745 | 48,238 | 9,745 | |
Jul 19 2016 | CDNA | CareDx, Inc. | Bickerstaff George | Director | Grant | A | 0.00 | 5,000 | 0 | 16,146 | 11.1 K to 16.1 K (+44.86 %) |
Jul 06 2016 | CDNA | CareDx, Inc. | Bickerstaff George | Director | Grant | A | 0.00 | 1,236 | 0 | 11,146 | 9.9 K to 11.1 K (+12.47 %) |
Jun 20 2016 | CDNA | CareDx, Inc. | Bickerstaff George | Director | Option Exercise | A | 5.02 | 5,255 | 26,380 | 5,255 | |
May 06 2016 | ARIA | ARIAD PHARMACEUTIC ... | Bickerstaff George | Director | Option Exercise | A | 6.65 | 75,000 | 498,750 | 75,000 | |
Apr 05 2016 | CDNA | CareDx, Inc. | Bickerstaff George | Director | Grant | A | 0.00 | 1,628 | 0 | 9,910 | 8.3 K to 9.9 K (+19.66 %) |
Jan 05 2016 | CDNA | CareDx, Inc. | Bickerstaff George | Director | Grant | A | 0.00 | 1,530 | 0 | 8,282 | 6.8 K to 8.3 K (+22.66 %) |
Oct 05 2015 | CDNA | CareDx, Inc. | Bickerstaff George | Director | Grant | A | 0.00 | 1,260 | 0 | 6,752 | 5.5 K to 6.8 K (+22.94 %) |
Jul 06 2015 | CDNA | CareDx, Inc. | Bickerstaff George | Director | Grant | A | 0.00 | 1,534 | 0 | 5,492 | 4 K to 5.5 K (+38.76 %) |
Jun 17 2015 | CDNA | CareDx, Inc. | Bickerstaff George | Director | Option Exercise | A | 6.08 | 5,255 | 31,950 | 5,255 | |
Apr 03 2015 | CDNA | CareDx, Inc. | Bickerstaff George | Director | Grant | A | 0.00 | 1,263 | 0 | 3,958 | 2.7 K to 4 K (+46.86 %) |
Dec 12 2008 | VION | VION PHARMACEUTICA ... | Bickerstaff George | Director | Grant | A | 0.00 | 1,130 | 0 | 9,683 | 8.6 K to 9.7 K (+13.21 %) |
Jun 28 2007 | VION | VION PHARMACEUTICA ... | Bickerstaff George | Director | Grant | A | 0.00 | 11,300 | 0 | 85,535 | 74.2 K to 85.5 K (+15.22 %) |
Mar 14 2007 | VION | VION PHARMACEUTICA ... | Bickerstaff George | Director | Buy | P | 1.75 | 13,900 | 24,325 | 74,235 | 60.3 K to 74.2 K (+23.04 %) |
Mar 14 2007 | VION | VION PHARMACEUTICA ... | Bickerstaff George | Director | Buy | P | 1.74 | 6,600 | 11,484 | 60,335 | 53.7 K to 60.3 K (+12.28 %) |
Mar 14 2007 | VION | VION PHARMACEUTICA ... | Bickerstaff George | Director | Buy | P | 1.76 | 19,500 | 34,320 | 53,735 | 34.2 K to 53.7 K (+56.96 %) |
Mar 14 2007 | VION | VION PHARMACEUTICA ... | Bickerstaff George | Director | Buy | P | 1.77 | 10,000 | 17,700 | 34,235 | 24.2 K to 34.2 K (+41.26 %) |
Jun 28 2006 | VION | VION PHARMACEUTICA ... | Bickerstaff George | Director | Grant | A | 0.00 | 11,300 | 0 | 24,235 | 12.9 K to 24.2 K (+87.36 %) |
Nov 18 2005 | VION | VION PHARMACEUTICA ... | Bickerstaff George | Director | Grant | A | 0.00 | 12,935 | 0 | 12,935 | 0 to 12.9 K |
Jun 09 2005 | VION | VION PHARMACEUTICA ... | Bickerstaff George | Director | Option Exercise | A | 2.09 | 20,000 | 41,800 | 20,000 |
Page: 1